Monster Beverage Corporation (NASDAQ:MNST) reported earnings of $229 million, or $1.26 a share, up from year-ago earnings of $141 million, or 81 cents a share. On an adjusted basis, per-share earnings fell to 79 cents from 82 cents, which also reflects an increase in shares outstanding. Sales rose about 1% to $693.7 million. The company said unfavorable currency-exchange rates reduced sales by about $23.9 million. Monster Beverage Corporation (NASDAQ:MNST) belongs to Consumer Goods sector. Its net profit margin is 15.40% and weekly performance is -4.80%. On last trading day company shares ended up $144.87. Monster Beverage Corporation (NASDAQ:MNST) distance from 50-day simple moving average (SMA50) is 5.79%.
NVIDIA Corporation (NASDAQ: NVDA) reported revenue for the second quarter ended July 26, 2015, of $1.153 billion, up 5 percent from $1.103 billion a year earlier, and up marginally from $1.151 billion the previous quarter. GAAP earnings per diluted share for the quarter were $0.05. This includes a charge of $0.19 per diluted share in connection with the company’s decision to wind down its Icera® modem operations, after a viable buyer failed to emerge. NVIDIA Corporation (NASDAQ:NVDA) shares moved down -0.63% in last trading session and ended the day at $20.45. NVDA Gross Margin is 56.00% and its return on assets is 8.90%. NVIDIA Corporation (NASDAQ:NVDA) quarterly performance is -8.65%.
JD.com Inc, (NASDAQ:JD) reported a 61 per cent year-on-year rise in second quarter revenues, topping expectations, powered by a jump in the number of shoppers and goods bought on its platform. JD.com’s revenues of 45.9 billion yuan ($7.39 billion) exceeded estimates of 44.45 billion yuan, according to a Thomson Reuters I/B/E/S poll of 14 analysts. On 06 August, JD.com, Inc. (NASDAQ:JD) shares moved down -4.40% and was closed at $32.81. JD.com, Inc. (NASDAQ:JD) year to date (YTD) performance is 41.79%.
On 3 August, Omeros Corporation (NASDAQ: OMER) announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain. Omeros Corporation (NASDAQ:OMER) ended the last trading day at $14.82. Company weekly volatility is calculated as 5.68% and price to cash ratio as 8.01. Omeros Corporation (NASDAQ:OMER) showed a weekly performance of -8.29%.
On 4 August, Sprint Corporation (NYSE:S) reported operating results for the first fiscal quarter of 2015, including record low Sprint platform postpaid churn of 1.56 percent, total net additions of 675,000, and for the fifth consecutive quarter, reduced postpaid phone losses to reach phone net additions in May and June. Sprint Corporation (NYSE:S) shares moved up 4.44% in last trading session and ended the day at $3.29. S Gross Margin is 45.10% and its return on assets is -4.00%. Sprint Corporation (NYSE:S) quarterly performance is -30.44%.